Achieve Life Sciences Management
Management criteria checks 3/4
Achieve Life Sciences' CEO is John Bencich, appointed in Sep 2020, has a tenure of 3.58 years. total yearly compensation is $1.50M, comprised of 33.9% salary and 66.1% bonuses, including company stock and options. directly owns 0.22% of the company’s shares, worth $338.35K. The average tenure of the management team and the board of directors is 5.1 years and 2.6 years respectively.
Key information
John Bencich
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 33.9% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.2% |
| Management average tenure | 5.1yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?
Jan 27
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?
Oct 26Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Mar 26Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation
Jun 29Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug
Apr 04Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?
Mar 22Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?
Sep 27We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully
Jun 14We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate
Mar 01Achieve Life Sciences prices stock offering at $7; shares down 2%
Dec 03Achieve Life Sciences launches equity offering
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$42m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$2m | US$510k | -US$42m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$33m |
| Dec 31 2021 | US$2m | US$465k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$31m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$884k | US$421k | -US$15m |
| Sep 30 2020 | n/a | n/a | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$571k | US$405k | -US$16m |
| Sep 30 2019 | n/a | n/a | -US$17m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$695k | US$376k | -US$13m |
| Sep 30 2018 | n/a | n/a | -US$13m |
| Jun 30 2018 | n/a | n/a | -US$16m |
| Mar 31 2018 | n/a | n/a | -US$13m |
| Dec 31 2017 | US$1m | US$336k | -US$11m |
Compensation vs Market: John's total compensation ($USD1.50M) is about average for companies of similar size in the US market ($USD1.60M).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Bencich (46 yo)
3.6yrs
Tenure
US$1,504,795
Compensation
Mr. John A. Bencich, M.B.A., serves as Chief Executive Officer and Director at Achieve Life Sciences, Inc since September 28, 2020. He served as an Executive Vice President and Chief Operating Officer at A...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.3yrs | US$1.27m | 0.11% $ 171.4k | |
| CEO & Director | 3.6yrs | US$1.50m | 0.22% $ 338.4k | |
| President | 3.6yrs | US$1.12m | 0.053% $ 80.5k | |
| Principal Accounting Officer | no data | no data | no data | |
| Chief Scientific Officer | 6.7yrs | US$589.66k | no data | |
| Executive Vice President of Commercial | 7.3yrs | no data | no data |
5.1yrs
Average Tenure
64yo
Average Age
Experienced Management: ACHV's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.3yrs | US$1.27m | 0.11% $ 171.4k | |
| CEO & Director | 3.6yrs | US$1.50m | 0.22% $ 338.4k | |
| President | 3.1yrs | US$1.12m | 0.053% $ 80.5k | |
| Director | 1.1yrs | no data | 0% $ 0 | |
| Independent Director | 2.1yrs | US$74.22k | 0% $ 0 | |
| Director | 1.1yrs | no data | 0% $ 0 | |
| Director | 1.1yrs | no data | 0% $ 0 | |
| Independent Director | 3.1yrs | US$81.86k | 0% $ 0 |
2.6yrs
Average Tenure
62yo
Average Age
Experienced Board: ACHV's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.